Introduction
============

Hepatitis C virus (HCV) infects over 170 million humans worldwide, of whom 70%--80% become long-term carriers. Only a minority of infected individuals clear the virus spontaneously, whereas 30--60% of them develop chronic liver disease and a substantial percentage develops cirrhosis or even hepatocellular carcinoma.[@b1-hmer-9-027],[@b2-hmer-9-027] Egypt has the highest prevalence of hepatitis C in the world.[@b3-hmer-9-027] The 2008 Egyptian Demographic Health Survey measured the HCV prevalence as 14.7% among a nationally representative sample of 11,126 Egyptians aged 15--59 years.[@b4-hmer-9-027]

Transmission of HCV infection usually occurs through parenteral route, including needle sharing and occupational injuries caused by contaminated needles, tattooing, and hemodialysis or contaminated medical equipments. However, at least 50% of all HCV-positive patients do not have a clear history of parenteral or other risk factors.[@b5-hmer-9-027] In areas with a high prevalence, intrafamilial transmission is suggested to play an important role. In its common use, intrafamilial transmission refers to transmission occurring between patients infected with HCV and their household members including their immediate relatives, sexual partners, and other individuals sharing the same house despite the absence of a common genetic background. Because of shared behaviors and living conditions, family members within a household are likely to be more similar to one another than relatives from different households. The two patterns of intrafamilial transmission of HCV are horizontal transmission and perinatal transmission. Perinatal transmission was studied and was found to have a minimal role in the transmission even in Egypt with no difference from figures all over the world.[@b6-hmer-9-027],[@b7-hmer-9-027]

Horizontal transmission is the spread of HCV from one person to another who are not in a mother--child relationship in the pre- and/or perinatal period.[@b8-hmer-9-027] The study of horizontal intrafamilial transmission is complicated. The routes of horizontal intrafamilial transmission of HCV are multiple and often vary among different geographical areas, and such a transmission can occur simultaneously in the same family.[@b9-hmer-9-027],[@b10-hmer-9-027] For a large proportion of HCV-infected patients who had not been exposed to any obvious risk factor, intrafamilial transmission was suspected; however, the occurrence of such transmission has been debated.[@b11-hmer-9-027]

Aim
===

The aim of this study was to estimate the prevalence of HCV infection among household contacts of known HCV patients in comparison with noninfected persons and identify the possible risk factors for the transmission of HCV.

Patients and methods
====================

This study was designed as a cohort study of household contacts of 90 HCV-positive patients (exposed group) in compari-son with household contacts of 38 non-HCV-infected persons (nonexposed group). The study protocol was approved by the ethical committee of Benha Faculty of Medicine. All patients and volunteer subjects gave written informed consent before the study. Index-positive patients were defined as patients with positive HCV antibodies (Abs) detected by fourth-generation enzyme-linked immunosorbent assay (ELISA) and confirmed by HCV RNA polymerase chain reaction (PCR). These patients were recruited from the Department of Hepatology, Gastroenterology, and Infectious Diseases, Benha University Hospital (outpatient and inpatient clinic). Index-negative subjects were defined as non-HCV-infected volunteer individuals diagnosed as negative for HCV Abs by ELISA, who were recruited from the same geographical area as index-positive patients. Benha University Hospital receives patients from almost all rural and some urban areas of Qalyubia, Monufia, Gharbia, and Sharqia governorates, which are part of the Nile Delta area. Household contacts were defined as persons who were living with the index subject in the same house for at least 1 year. A pre-prepared questionnaire on demographic data and risk factors was filled by a single interviewer. Socioeconomic status was classified according to a well-validated simple scoring system for social classification in Egypt.[@b12-hmer-9-027] Detailed clinical history, including suggested risk factors for possible intrafamilial transmission, was evaluated, and clinical examination, laboratory investigation, and abdominal ultrasound were performed for all HCV-positive index and data were collected.

Laboratory methods
------------------

At the time of family interview, 3 mL of peripheral blood was withdrawn from each subject into a sterile vacutainer and allowed to clot. After centrifugation, the obtained sera were aliquoted and kept frozen at −20°C till further processing.

Serum samples were used for detection of serum HCV Abs (IgG) in duplicates, using Murex anti-HCV (version 4.0) ELISA kit (Murex Biotech, Dartford, UK), on a microplate reader (Tecan, Männedorf, Switzerland).[@b13-hmer-9-027] The reactive sam-ples were then used for quantification of HCV load in serum.

The QIAamp Viral RNA Mini Kits were used for viral RNA extraction by Qiacube automatic extractor (Qiagen, Hilden, Germany). Quantitative real-time (RT) PCR assays were performed by absolute quantitation method using artus HCV RG RT-PCR Kit (Qiagen). Four quantitation standards were used to generate standard curves on Step One RT-PCR system (Applied Biosystems, Foster City, CA, USA). The results were calculated using the following equation: $$\begin{array}{l}
{\text{result}\ \left( \text{IU}/\text{mL} \right) = \text{result}\ (\text{IU}/\mu L) \times \text{elution~volume}\ (\mu L)/\text{sample}} \\
{\text{volume}\ (\text{mL}).} \\
\end{array}$$

The manufacturers' instructions were followed throughout all the steps.

The prevalence of HCV among household contacts of positive and negative index was calculated with 95% confidence interval (CI), and comparison between them was made by using Chi-square test. Comparison between families of positive index and families of negative index was made with calculation of odds ratio (OR). Univariate and multivariate analyses were carried out for comparing infected contacts with noninfected contacts to identify risk factors.

Results
=======

We included 90 families with HCV-positive index with their contacts (257 persons), and 38 families with HCV-negative index with their contacts (75 persons). [Table 1](#t1-hmer-9-027){ref-type="table"} shows the descriptive data of the index-positive patients, index-negative patients, and their contacts. The majority of studied subjects were males, and the mean age was higher among the HCV-positive-index cases (52.1 ± 9.6 years) than other groups. Most of our population was from rural areas with a middle socioeconomic standard of living.

Comparison between HCV-positive and HCV-negative patients by univariate and logistic regression analyses to identify the risk factors for acquisition of HCV in our population is shown in [Tables 2](#t2-hmer-9-027){ref-type="table"} and [3](#t3-hmer-9-027){ref-type="table"}. The independent predictors of risk factors for HCV infection in general were male gender (*P* \< 0.001), advanced age (*P* \< 0.001), and exposure to blood transfusion (*P* = 0.03) ([Table 3](#t3-hmer-9-027){ref-type="table"}).

Regarding intrafamilial transmission, out of 90 families with HCV-positive index, 32 of them (35.6%) had one or more HCV-positive contact in comparison to two out of 38 families (5.3%) with HCV-negative index (*P* \< 0.001, OR = 9.93, 95% CI = 2.24--43.97). This means that families with one positive member have almost a tenfold increased risk of having another positive member within the family. Out of 257 index-positive contacts, 38 (14.8%) were infected in comparison with three of 75 (4%) index-negative contacts (*P* = 0.01, OR = 4.3, 95% CI = 1.3--14.5). This means that each family member in contact with the HCV-positive patient has almost a fourfold increased risk of getting infected.

There was a highly statistically significant difference in the prevalence of HCV among different age groups; prevalence was high (22%) in the advanced age group (≥40 years) ([Table 4](#t4-hmer-9-027){ref-type="table"}). Regarding the relation between HCV status and kinship to index cases, we demonstrated that husbands of HCV-positive females were at a higher risk followed by sons (33.3% and 16.9%, respectively) and wives of HCV-positive males and daughters (13.5% and 5.1%, respectively) ([Table 5](#t5-hmer-9-027){ref-type="table"}). Regarding the duration of marriage, we found that HCV-positive cases had insignificantly longer duration of marriage than negative cases (*P* = 0.5).

Risk of intrafamilial transmission of HCV infection was higher in the decompensated liver cirrhosis group (30%) than control group (5.3%) with a highly statistically significant difference between both the groups (*P* = 0.004, OR = 7.71). However, there was an insignificant difference between compensated and decompensated liver cirrhosis groups due to HCV infection regarding risk of intrafamilial transmission (*P* = 0.2). There was a highly statistically significant difference between numbers of contact with HCV infection in families (94 families did not have any HCV-positive contacts, 27 families had only one HCV-positive contact, and seven families had two HCV-positive contacts) regarding presence of positive index cases, compensated liver cirrhosis, history of encephalopathy, history and presence of ascites, palmar erythema, and flabbing tremors ([Table 6](#t6-hmer-9-027){ref-type="table"}). By performing a logistic regression analysis of previous significant parameters, we found that only history of encephalopathy was the most prominent risk factor for intrafamilial transmission of HCV infection (*P* \< 0.001, OR = 5.422, 95% CI = 2.099--14.006).

Discussion
==========

Chronic hepatitis C (CHC) is a major health concern worldwide, and although often clinically silent, it is histologically an insidiously progressive disease leading to liver fibrosis, cirrhosis, and hepatocellular carcinoma.[@b14-hmer-9-027] Egypt has been reported to have the highest prevalence of HCV worldwide, ranging from 6% to more than 40% in different regions and among different demographic groups.[@b15-hmer-9-027] The route of transmission of HCV is still controversial and complicated. Transmission of blood or blood products leads to infection in the majority of cases.[@b16-hmer-9-027] The household contacts of HCV-seropositive patients had been shown to have an elevated risk of HCV infection.[@b11-hmer-9-027],[@b17-hmer-9-027] The present study revealed that the majority of studied patients were males, and this finding is in agreement with Mohamoud et al.[@b4-hmer-9-027] This result may be in part attributed to the parenteral antischistosomiasis therapy, as males were more affected by the schistosomiasis disease burden and hence were the main targets of these campaigns. We also found in this study that the mean age of HCV-positive cases was higher than HCV-negative cases (52.1 ± 9.6 and 38.9 ± 9.8 years, respectively). This observation was previously reported in two studies from Egypt, where adults had a higher HCV prevalence (15.7%) than children (4%).[@b15-hmer-9-027],[@b18-hmer-9-027] We also found that the majority of HCV-positive cases were from rural areas (92.2%). These data confirm that Egypt has the highest prevalence of HCV infection averaging 15%--25% in rural communities as previously reported by two other studies.[@b19-hmer-9-027],[@b20-hmer-9-027] In the current study, we demonstrated that male gender, advanced age, and exposure to blood transfusion in the whole studied population were risk factors for acquiring HCV infection. Minola et al reported similar results as they studied risk factors for intrafamilial transmission of HCV infection and found that age (OR = 1.01, *P* = 0.07), gender (females versus males: OR = 2.03, *P* \< 0.001), intravenous (IV) drug use (OR = 2.98, *P* \< 0.001), and blood transfusion (OR = 0.6, *P* = 0.03) were the major risk factors.[@b11-hmer-9-027]

Role of intrafamilial transmission in the high prevalence of HCV in Egypt was confirmed in our study. We found that 35.6% of families with HCV-positive index had a HCV-positive contact in comparison with only 5.2% of families with HCV-negative index. We also found that persons in contact with HCV-positive patients had a prevalence of 14.8% of HCV in comparison with 4% of those in contact with HCV-negative persons. Role of intrafamilial transmission was also previously reported by other authors from Egypt and other countries.[@b21-hmer-9-027],[@b22-hmer-9-027]

In the present work, the prevalence of HCV among husbands of infected females was 33.3% (3/9) and prevalence among wives of infected husbands was 13.5% (5/52), which suggests a higher transmission from infected wives to their husbands. However, this transmission had no significant association with the duration of marriage. Similar results were reported by El-Bendary et al,[@b16-hmer-9-027] who concluded that prevalence of positive anti-HCV Abs among wives was 17.8% (10/56), while the prevalence of positive anti-HCV Abs among husbands was 36.4% (8/22). However, they found that anti-HCV-positive spouses had longer duration of marriage than negative spouses, which was not confirmed in our study. Many studies reported that the longer the duration of marriage, the higher the risk of HCV infection. The risk of HCV infection for the spouse was found to be increased after 15 years.[@b23-hmer-9-027],[@b24-hmer-9-027] Marriage did not only include a sexual relationship but also other kinds of body contact and exposure to the same risk factors (ie, sharing the same personal tools, exposure to blood of the index case by any means).[@b25-hmer-9-027] In the current study, HCV prevalence rates were high among offspring (16.9% for sons and 5.1% for daughters) of HCV-positive cases. This result was in concordance with that reported by El-Bendary et al,[@b16-hmer-9-027] who found that the prevalence was 6.8% for sons and 4.94% for daughters. Several Japanese studies have revealed high prevalence rates among offspring of chronic HCV patients, for example, the study by Nishiguchi et al (20.9%) and Hayashi et al (16.9%).[@b26-hmer-9-027],[@b27-hmer-9-027] On the other hand, Napoli et al and Kim et al reported low prevalence rates among offspring (2.3% and 0%, respectively).[@b28-hmer-9-027],[@b29-hmer-9-027]

In the current study, we found that HCV positivity was significantly high among subjects aged ≥40 years (22%), and this agreed with the study by Arafa et al,[@b30-hmer-9-027] who reported that the prevalence of HCV Abs in rural area of Egypt increased from 2.7% in those \<20 years of age to more than 40% in males whose age ranged from 40 to 54 years. Similarly, Paez Jimenez et al reported that prevalence of chronic HCV infection in Egypt increased with age reaching \>25% among persons aged \>50 years.[@b10-hmer-9-027]

We also found that those in contact with patients with decompensated liver cirrhosis have a higher risk of being infected with HCV (OR = 7.71), especially if the patient has hepatic encephalopathy which is an independent predictor of infection. These findings could be explained by increased risky behaviors of those in contact with the cases without taking precautions, such as giving IV injections and doing enemas.

Limitations
===========

This study has some limitations. There is no temporal factor because it is not a prospective cohort study, and hence, there is a limitation of causality relationship. The second limitation is the absence of phylogenetic study which confirms the same genotype and subtype in the family. Another limitation is that we cannot rule out getting the infection for index and contacts from the same source outside the family.

Conclusion
==========

Intrafamilial transmission of HCV possibly plays an important role in the high prevalence of HCV in Egypt, which supports screening of family members of HCV patients. Contact with a family member with decompensated cirrhosis especially hepatic encephalopathy increases the risk of intrafamilial transmission which necessitates an educational program for families with a chronic liver disease patient.
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###### 

Description of the studied population

  Parameter                   HCV index positive (N = 90), n (%) or mean (±SD)   HCV index negative (N = 38), n (%) or mean (±SD)   Contact (N = 332), n (%) or mean (±SD)
  --------------------------- -------------------------------------------------- -------------------------------------------------- ----------------------------------------
  Gender, male                62 (68.9)                                          24 (63.2)                                          141 (42.5)
  Age (years)                 52.1 (±9.6)                                        38.9 (±8.9)                                        29.9 (±14.9)
  Occupation                                                                                                                        
   Not working                29 (32.2)                                          9 (23.7)                                           233 (70.2)
   Farmer                     20 (22.2)                                          2 (5.5)                                            16 (4.8)
   Worker                     12 (13.3)                                          3 (7.5)                                            21 (6.3)
   Technician                 12 (13.3)                                          4 (10.5)                                           26 (7.8)
   Professional               14 (15.6)                                          7 (18.4)                                           23 (6.9)
   Health care worker         3 (3.3)                                            13 (34.2)                                          13 (3.9)
  Residence                                                                                                                         
   Rural                      83 (92.2)                                          37 (97.4)                                          313 (94.3)
   Urban                      7 (7.8)                                            1 (7.9)                                            19 (5.7)
  Education                                                                                                                         
   Illiterate                 32 (35.6)                                          7 (18.4)                                           64 (19.3)
   Less than secondary        22 (24.4)                                          3 (7.9)                                            104 (31.3)
   Secondary                  18 (20)                                            11 (28.9)                                          103 (31)
   University                 18 (20)                                            17 (44.7)                                          61 (18.4)
  Socioeconomic status                                                                                                              
   Low                        15 (16.7)                                          3 (7.9)                                            38 (10.4)
   Middle                     68 (75.6)                                          32 (84.2)                                          269 (81)
   High                       7 (7.7)                                            3 (7.9)                                            25 (7.6)
  Marital status                                                                                                                    
   Not married                3 (3.3)                                            3 (7.9)                                            137 (41.3)
   Married                    76 (84.4)                                          32 (84.2)                                          185 (55.7)
   Divorced                   0                                                  0 (0)                                              1 (0.3)
   Widow                      11 (12.2)                                          3 (7.9)                                            9 (2.7)
  Anti-bilharzial treatment                                                                                                         
   No                         11 (12.2)                                          4 (10.5)                                           154 (46.4)
   Oral                       72 (80)                                            34 (89.5)                                          173 (52.1)
   Parenteral                 3 (3.3)                                            0 (0)                                              4 (1.2)
   Both                       4 (4.5)                                            0 (0)                                              1 (0.3)
  Previous operation          66 (73.3)                                          22 (57.9)                                          165 (49.7)
  Blood transfusion           39 (43.3)                                          7 (18.4)                                           45 (13.6)
  Injection, medication       77 (85.6)                                          35 (92.1)                                          213 (64.2)
  Dental procedure            44 (49.5)                                          30 (78.9)                                          167 (50.3)
  Dialysis                    7 (7.8)                                            0 (0)                                              2 (0.6)

**Abbreviations:** HCV, hepatitis C virus; SD, standard deviation.

###### 

Comparison between HCV-positive and HCV-negative studied population

  Parameters                      HCV positive (N = 131), n (%) or mean (±SD)   HCV negative (N = 329), n (%) or mean (±SD)   *P*-value
  ------------------------------- --------------------------------------------- --------------------------------------------- -----------
  Gender, male                    83 (63.4)                                     144 (43.8)                                    \<0.001
  Age (years)                     47.2 (±13.8)                                  30.1 (±14.4)                                  \<0.001
  Occupation                                                                                                                  
   Not working                    53 (40.5)                                     218 (66.3)                                    \<0.001
   Farmer                         23 (17.6)                                     15 (4.6)                                      
   Worker                         17 (13)                                       19 (5.8)                                      
   Technician                     14 (10.7)                                     28 (8.5)                                      
   Professional                   20 (15.3)                                     24 (7.3)                                      
   Health care worker             4 (3.1)                                       25 (7.6)                                      
  Residence                                                                                                                   
   Rural                          122 (93.1)                                    311 (94.5)                                    0.6
  Education                                                                                                                   
   Illiterate                     42 (32.1)                                     61 (18.5)                                     0.016
   Less than secondary            35 (26.7)                                     94 (28.6)                                     
   Secondary                      31 (23.7)                                     101 (30.7)                                    
   University                     23 (17.6)                                     73 (22.2)                                     
  Socioeconomic status                                                                                                        
   Low                            20 (15.3)                                     36 (10.9)                                     0.4
   Middle                         102 (77.9)                                    267 (81.2)                                    
   High                           9 (6.8)                                       26 (7.9)                                      
  Marital status                                                                                                              
   Not married                    14 (10.7)                                     129 (39.2)                                    \<0.001
   Married                        103 (78.6)                                    191 (58.1)                                    
   Divorced                       0 (0)                                         1 (0.3)                                       
   Widow                          14 (10.7)                                     8 (2.4)                                       
   Duration of marriage (years)   22.5 (±13.1)                                  9.5 (±11.5)                                   \<0.001
  Anti-bilharzial treatment                                                                                                   
   No                             20 (15.3)                                     149 (45.3)                                    \<0.001
   Oral                           103 (78.6)                                    176 (53.5)                                    
   Parenteral                     4 (3.1)                                       3 (0.9)                                       
   Both                           4 (3.1)                                       1 (0.3)                                       
  Previous operation              90 (68.7)                                     163 (49.5)                                    \<0.001
  Blood transfusion               44 (33.6)                                     47 (14.3)                                     \<0.001
  Injection, medication           108 (82.4)                                    217 (66)                                      \<0.001
  Dental procedure                66 (50.8)                                     175 (53.2)                                    0.7
  Dialysis                        8 (6.1)                                       1 (0.3)                                       \<0.001

**Abbreviations:** HCV, hepatitis C virus; SD, standard deviation.

###### 

Forward logistic regression analysis of predictors of HCV infection

  Predictors          OR      95% CI         *P*-value
  ------------------- ------- -------------- -----------
  Gender, female      0.29    0.174--0.488   \<0.001
  Age                 1.085   1.065--1.106   \<0.001
  Blood transfusion   1.914   1.066--3.436   0.03

**Abbreviations:** HCV, hepatitis C virus; OR, odds ratio; CI, confidence interval.

###### 

Distribution of HCV status among household contacts according to age group

  Age group (years)   HCV positive, n (%)   HCV negative, n (%)   Total   *P*-value
  ------------------- --------------------- --------------------- ------- -----------
  \<20                6 (6.9)               81 (93.1)             83      0.007
  20--39              17 (10.4)             146 (89.6)            163     
  ≥40                 18 (22)               64 (78)               82      

**Abbreviation:** HCV, hepatitis C virus.

###### 

Distribution of HCV status among contacts of index-positive cases according to degree of kinship to index

  Degree of kinship   HCV positive (N = 38, 14.8%), n (%)   HCV negative (N = 219, 85.2%), n (%)   Total (N = 257)   *P*-value
  ------------------- ------------------------------------- -------------------------------------- ----------------- -----------
  Husband             3 (33.3)                              6 (66.7)                               9                 \<0.000
  Wife                7 (13.5)                              45 (86.5)                              52                
  Son                 13 (16.9)                             64 (83.1)                              77                
  Daughter            3 (5.1)                               56 (94.9)                              59                
  Sister              3 (20)                                12 (80)                                15                
  Brother             1 (12.5)                              7 (87.5)                               8                 
  Others              8 (17.1)                              39 (82)                                47                

**Abbreviation:** HCV, hepatitis C virus.

###### 

Comparison between families with no HCV-positive, single HCV-positive, and two HCV-positive contacts

                               Number of families (number of contacts), n (%)   *P*-value              
  ---------------------------- ------------------------------------------------ ----------- ---------- -------
  Index positive               58 (61.7)                                        26 (96.3)   6 (85.7)   0.002
  Decompensated cirrhosis      23 (24.5)                                        13 (48.1)   4 (57.1)   0.004
  Previous history                                                                                     
   Encephalopathy              10 (10.6)                                        13 (48.1)   3 (42.9)   0.001
   Gastrointestinal bleeding   12 (12.7)                                        6 (22.2)    2 (28.6)   0.6
   Ascites                     16 (17.1)                                        14 (51.9)   4 (57.1)   0.006
  Pallor                       38 (40.4)                                        16 (59.3)   5 (71.4)   0.6
  Jaundice                     21 (22.3)                                        11 (40.7)   4 (57.1)   0.2
  Cyanosis                     7 (7.4)                                          7 (25)      1 (14.3)   0.1
  Palmar erythema              24 (25.5)                                        16 (59.3)   5 (71.4)   0.02
  Flabbing tremors             12 (12.7)                                        11 (40.7)   3 (42.9)   0.03
  Palpable spleen              24 (25.5)                                        14 (51.9)   3 (42.9)   0.3
  Palpable liver               13 (13.8)                                        3 (11.1)    2 (28.6)   0.5
  Ascites                                                                                              0.003
   Mild                        6 (8.5)                                          3 (11.1)    2 (28.6)   
   Moderate                    2 (2.8)                                          6 (22.2)    2 (28.6)   
   Severe                      6 (8.5)                                          5 (18.5)    1 (14.3)   

**Abbreviation:** HCV, hepatitis C virus.
